196 filings
Page 7 of 10
UPLOAD
qn2hbaqde bit9vfdo
27 May 22
Letter from SEC
12:00am
F-3
vjo6j6uk
20 May 22
Shelf registration (foreign)
5:22pm
6-K
p4bl8mbr
19 May 22
Current report (foreign)
12:00am
6-K
vxc3x
12 May 22
Current report (foreign)
4:35pm
6-K
sjewoy
11 May 22
Evaxion Biotech Announces First Quarter 2022 Financial Results and Provides Business Update
7:30am
6-K
opzo p01d
10 May 22
Current report (foreign)
5:25pm
6-K
2lw6qf5e qn4ngt
6 May 22
Current report (foreign)
4:32pm
6-K
dauvt h7pak
12 Apr 22
Notice of Annual General Meeting
4:31pm
6-K
c6mnow icegmh88fl6
5 Apr 22
Current report (foreign)
9:29am
6-K
8pt6s zqvajj
23 Mar 22
Current report (foreign)
8:25am
6-K
7lq49439h7u0bx 1ua
22 Mar 22
Evaxion Biotech Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
6:30am
6-K
6z3lp
15 Mar 22
Evaxion Biotech Strengthens Management Team with Two Senior Appointments
9:26am
6-K
0i8p6djjqgt p3
7 Mar 22
Evaxion Biotech Completes Recruitment for Phase 1/2a Clinical Trial for EVX-02
4:17pm
6-K
joa6nmi1i64ovbd761
11 Feb 22
Current report (foreign)
5:00pm
6-K
zt0x11xf
18 Jan 22
Evaxion Biotech Receives Regulatory Clearance to Initiate Phase 2 Trial of EVX-01 in Combination with KEYTRUDA® for Treatment of Melanoma
4:30pm
6-K
5qd6tsuyovxdm6 tv5
10 Nov 21
Current report (foreign)
4:40pm
6-K
zxa4rh3
9 Nov 21
Current report (foreign)
5:00pm
6-K
pim1kvswetgpte7e8q
9 Nov 21
Evaxion Biotech Announces Q3 2021 Financial Results and Provides Business Update
6:29am
424B4
hotu3
5 Nov 21
Prospectus supplement with pricing info
4:47pm